US Patent Issued to DANA-FARBER CANCER INSTITUTE on May 26 for "Tricyclic kinase inhibitors and uses thereof" (Massachusetts, California, Illinois Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,463, issued on May 26, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Tricyclic kinase inhibitors and uses thereof" was invented by Nathanael S. Gray (Stanford, Calif.), Tinghu Zhang (Brookline, Mass.), Yao Liu (Brookline, Mass.), David Weinstock (Jamaica Plain, Mass.) and Loretta Sze-Mun Li (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof. The provided compounds may be kinase (e.g., Janus kina...